GRI Bio (GRI) Financials: Revenue & Earnings
GRI$1.60+0.02 +1.27%
$3.50M
Market Cap
—
P/E
—
Forward P/E
—
Score
GRI Bio (GRI) Financials: Revenue & Earnings
GRI price $1.60 +0.02 +1.27%
- Ticker
- GRI
- Price
- $1.60
- Change
- +0.02 +1.27%
- Market cap ?
- $3.50M
- Beta ?
- -0.61
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
GRI fair value $12.77. Price $1.60. Price is 87% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-13 | — | -0.84 | — | — |
| 2026-08-14 | -0.91 | -1.19 | — | — |
| 2026-05-13 | -1.61 | -0.91 | — | — |
| 2026-03-13 | -13.25 | -29.27 | — | — |
| 2025-11-14 | -35.85 | -29.26 | — | — |
| 2025-08-14 | -36.69 | -36.69 | — | — |
| 2025-08-12 | -162.40 | -1.31 | — | — |
| 2025-05-15 | -162.40 | -105.98 | — | — |
| 2024-11-14 | -319.18 | -347.48 | — | — |
| 2024-09-16 | -1,731.80 | — | — | — |
| 2024-08-14 | -2,343.79 | — | — | — |
| 2024-05-10 | -2,849.61 | — | — | — |
| 2023-11-14 | -22,542.35 | — | — | — |
| 2023-08-14 | -120,858.64 | — | — | — |
| 2023-05-15 | -1,218.82 | — | — | — |
| 2023-02-24 | -152,572.00 | -376,849.20 | — | — |
| 2022-11-03 | -110,884.76 | -324,870.00 | — | — |
| 2022-07-28 | -9,282.00 | -10,674.30 | — | — |
| 2022-05-09 | -545.44 | -46.20 | — | — |
| 2022-02-14 | -46.20 | -46.20 | — | — |
| 2021-09-30 | -1,410.77 | — | — | — |
| 2021-06-30 | -2,594.84 | — | — | — |
| 2021-03-31 | -2,960.72 | — | — | — |
| 2020-12-31 | -1,648.71 | — | — | — |
| 2020-09-30 | -1,172.84 | — | — | — |
| 2020-06-30 | -1,287.32 | — | — | — |
| 2020-03-31 | -1,303.03 | — | 100.00K | — |
| 2019-12-31 | -978.11 | — | — | — |
| 2019-09-30 | -1,065.10 | — | — | — |
| 2019-06-30 | -1,084.18 | — | — | — |
| 2019-03-31 | -760.94 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency Irregular.
Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2008-12-29 | $0.49 | — | — | Irregular |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2025-09-18 | Kelly Leanne | Buy | 43.22K | $1.93 | 83.42K |
| 2025-09-18 | Szekeres David Leslie | Buy | 39.90K | $1.93 | 77.00K |
| 2025-09-18 | Baker David Charles | Buy | 23.61K | $1.93 | 45.56K |
| 2025-09-18 | SIMPSON CAMILLA V | Buy | 23.61K | $1.93 | 45.56K |
| 2025-09-18 | Chaturvedi Vipin | Buy | 43.22K | $1.93 | 83.42K |
| 2025-09-18 | Rongen Roelof | Buy | 23.61K | $1.93 | 45.56K |
| 2025-09-18 | Hertz Walter Marc | Buy | 103.07K | $1.93 | 198.92K |
| 2025-08-26 | Hertz Walter Marc | Buy | 26.69K | $1.41 | 37.63K |
| 2025-08-26 | Szekeres David Leslie | Buy | 10.28K | $1.41 | 14.49K |
| 2025-08-26 | Baker David Charles | Buy | 5.99K | $1.41 | 8.45K |
| 2025-08-26 | Rongen Roelof | Buy | 5.99K | $1.41 | 8.45K |
| 2025-08-26 | Chaturvedi Vipin | Buy | 11.85K | $1.41 | 16.71K |
| 2025-08-26 | SIMPSON CAMILLA V | Buy | 5.99K | $1.41 | 8.45K |
| 2025-08-26 | Kelly Leanne | Buy | 11.85K | $1.41 | 16.71K |
| 2025-08-13 | SIMPSON CAMILLA V | Buy | 4.53K | $1.30 | 5.89K |
| 2025-08-13 | Baker David Charles | Buy | 4.53K | $1.30 | 5.89K |
| 2025-08-13 | Rongen Roelof | Buy | 4.53K | $1.30 | 5.89K |
| 2025-08-13 | Szekeres David Leslie | Buy | 7.54K | $1.30 | 9.81K |
| 2025-01-23 | Kelly Leanne | Buy | 43.32K | $0.69 | 29.70K |
| 2025-01-23 | Chaturvedi Vipin | Buy | 43.32K | $0.69 | 29.70K |
| 2025-01-23 | Hertz Walter Marc | Buy | 129.73K | $0.69 | 88.96K |
| 2025-01-23 | SIMPSON CAMILLA V | Buy | 30.30K | $0.69 | 20.77K |
| 2025-01-23 | Baker David Charles | Buy | 30.30K | $0.69 | 20.77K |
| 2025-01-23 | Szekeres David Leslie | Buy | 51.94K | $0.69 | 35.61K |
| 2025-01-23 | Rongen Roelof | Buy | 30.30K | $0.69 | 20.77K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 11, holders +5 vs prior quarter. Ownership 5.18%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| HRT FINANCIAL LP | 28.78K | 28.78K | New | 50.00K |
| VANGUARD CAPITAL MANAGEMENT LLC | 21.37K | 21.37K | New | 37.82K |
| GEODE CAPITAL MANAGEMENT, LLC | 13.87K | -4.57K | -24.78% | 24.55K |
| CITADEL ADVISORS LLC | 13.38K | 13.38K | New | 23.68K |
| MORGAN STANLEY | 8.74K | 8.74K | New | 15.46K |
| UBS GROUP AG | 4.92K | -3.80K | -43.59% | 8.71K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 2.43K | 1.37K | +129.62% | 4.31K |
| BARCLAYS PLC | 83 | 83 | New | 147 |
| BLACKROCK, INC. | 7 | 0 | 0.00% | 12 |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 2 | 2 | New | 4 |
| DANSKE BANK A/S | 2 | 0 | 0.00% | 4 |
| SBI SECURITIES CO., LTD. | 0 | -4 | -100.00% | 0 |
Earnings and financials
GRI Bio, Inc. (GRI) trades at $1.60, with a market cap of $3.50M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn